{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:34:01Z","timestamp":1793234041015,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.phrs.2020.105048","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T12:25:47Z","timestamp":1592915147000},"page":"105048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Global research on artemisinin and its derivatives: Perspectives from patents"],"prefix":"10.1016","volume":"159","author":[{"given":"Kunmeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huali","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.phrs.2020.105048_bib0005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (Qinghaosu) and gifts from chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.105048_bib0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.medmal.2018.01.004","article-title":"Use of artesunate in non-malarial indications","volume":"48","author":"Raffetin","year":"2018","journal-title":"Med. Mal. Infect."},{"issue":"6_Suppl","key":"10.1016\/j.phrs.2020.105048_bib0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2020.105048_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drup.2005.04.003","article-title":"Mechanistic perspectives for 1, 2, 4-trioxanes in anti-cancer therapy","volume":"8","author":"Efferth","year":"2005","journal-title":"Drug Resist. Update"},{"issue":"1","key":"10.1016\/j.phrs.2020.105048_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4196\/kjpp.2015.19.1.21","article-title":"Anti-inflammatory, antioxidant and antimicrobial effects of artemisinin extracts from Artemisia Annua L","volume":"19","author":"Kim","year":"2015","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105048_bib0030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2020.105048_bib0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1756-3305-4-201","article-title":"Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis","volume":"4","author":"Liu","year":"2011","journal-title":"Parasites Vectors"},{"issue":"6","key":"10.1016\/j.phrs.2020.105048_bib0040","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/np50096a007","article-title":"Cytotoxicity of artemisinin-related endoperoxides to ehrlich ascites tumor cells","volume":"56","author":"Woerdenbag","year":"1993","journal-title":"J. Nat. Prod."},{"issue":"13","key":"10.1016\/j.phrs.2020.105048_bib0045","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.phymed.2015.10.003","article-title":"Nobel prize for artemisinin brings phytotherapy into the spotlight","volume":"22","author":"Efferth","year":"2015","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.phrs.2020.105048_bib0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pt.2010.11.006","article-title":"Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets","volume":"27","author":"Ding","year":"2011","journal-title":"Trends Parasitol."},{"issue":"10","key":"10.1016\/j.phrs.2020.105048_bib0055","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2008.07.004","article-title":"Artemisinins: their growing importance in medicine","volume":"29","author":"Krishna","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"13","key":"10.1016\/j.phrs.2020.105048_bib0060","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2174\/13895575113136660097","article-title":"Malaria and artemisinin derivatives: an updated review","volume":"13","author":"Tayyab Ansari","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"issue":"35","key":"10.1016\/j.phrs.2020.105048_bib0065","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1002\/anie.201601967","article-title":"Artemisinin\u2014a gift from traditional chinese medicine to the world (Nobel lecture)","volume":"55","author":"Tu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"11","key":"10.1016\/j.phrs.2020.105048_bib0070","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The prisma extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.phrs.2020.105048_bib0075","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nbt.4291","article-title":"The reporting items for patent landscapes statement","volume":"36","author":"Smith","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105048_bib0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2307\/2555502","article-title":"A penny for your quotes: patent citations and the value of innovations","volume":"21","author":"Trajtenberg","year":"1990","journal-title":"Rand J. Econ."},{"issue":"12","key":"10.1016\/j.phrs.2020.105048_bib0085","article-title":"Anticancer properties of distinct antimalarial drug classes","volume":"8","author":"Van Huijsduijnen","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2020.105048_bib0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Invest. New Drugs"},{"issue":"8","key":"10.1016\/j.phrs.2020.105048_bib0095","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-Approved compound library identifies four small-molecule inhibitors of middle east respiratory syndrome coronavirus replication in cell culture, antimicrob","volume":"58","author":"de Wilde","year":"2014","journal-title":"Agents Chemother."},{"issue":"3","key":"10.1016\/j.phrs.2020.105048_bib0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1371\/journal.pone.0194868","article-title":"Mers-Cov pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells","volume":"13","author":"Cong","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2020.105048_bib0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","author":"Al\u2010Bari","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.phrs.2020.105048_bib0110","series-title":"Mateon Therapeutics, Mateon Expands Its Covid-19 Therapeutic Program to Include Artemisinin","year":"2020"},{"key":"10.1016\/j.phrs.2020.105048_bib0115","series-title":"PHEXCOM, Looking at the Opportunity of \u201cNew Uses of Old Drugs\u201d From Chloroquine Phosphate","year":"2020"},{"issue":"8","key":"10.1016\/j.phrs.2020.105048_bib0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7154","key":"10.1016\/j.phrs.2020.105048_bib0125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.phrs.2020.105048_bib0130","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMp1901233","article-title":"A temporizing solution to \u201cArtemisinin resistance\u201d","volume":"380","author":"Wang","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.phrs.2020.105048_bib0135","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1473-3099(19)30535-3","article-title":"Suboptimal dosing triggers artemisinin partner drug resistance","volume":"19","author":"Wang","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2020.105048_bib0140","first-page":"142","article-title":"Collaborative research group on the structure of artemisinin, artemisinin, a new sesquiterpene lactone","volume":"22","year":"1977","journal-title":"Chin. Sci. Bull."},{"key":"10.1016\/j.phrs.2020.105048_bib0145","series-title":"Why Is It Important to Combine Malaria Drugs?","author":"WHO","year":"2006"},{"key":"10.1016\/j.phrs.2020.105048_bib0150","first-page":"21","article-title":"What does patent bring: review on the development of antimalarial drugs of artemisinin","volume":"7","author":"Ye","year":"2007","journal-title":"China Invent. Pat."},{"key":"10.1016\/j.phrs.2020.105048_bib0155","series-title":"ThePaper.cn, KPC: Participated in the Research and Development of Antimalarial Drugs for More Than 50 Years, and Will Promote the International Development of Artemisinin","year":"2019"},{"issue":"2","key":"10.1016\/j.phrs.2020.105048_bib0160","first-page":"189","article-title":"The protection of intellectual property rights of medical scientific research achievements from the history and current situation of artemisinin patent","volume":"11","author":"Li","year":"2016","journal-title":"Chin. Med. Biotechnol."},{"issue":"18","key":"10.1016\/j.phrs.2020.105048_bib0165","first-page":"233","article-title":"The mother of artemisinin: Tu Youyou, Chinese Nobel Laureate in Physiology or Medicine in 2015","author":"Zhu","year":"2016","journal-title":"China Mark."},{"issue":"1","key":"10.1016\/j.phrs.2020.105048_bib0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12936-015-0795-z","article-title":"Assessing the quality of anti-malarial drugs from gabonese pharmacies using the Minilab\u00ae: a field study","volume":"14","author":"Visser","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.phrs.2020.105048_bib0175","series-title":"WHO Briefing on Malaria Treatment Guidelines and Artemisinin Monotherapies","author":"WHO","year":"2006"},{"key":"10.1016\/j.phrs.2020.105048_bib0180","series-title":"Overview of Malaria Treatment","author":"WHO","year":"2018"},{"key":"10.1016\/j.phrs.2020.105048_bib0185","series-title":"Herbridge, Novartis Announced the Quantity of Artemisinin APIs Purchased This Year and Responded to the Oral Orders","year":"2007"},{"key":"10.1016\/j.phrs.2020.105048_bib0190","series-title":"Q&A on Artemisinin Resistance","author":"WHO","year":"2019"},{"key":"10.1016\/j.phrs.2020.105048_bib0195","series-title":"Coartem Has Entered Maturity Period","author":"Shi","year":"2007"},{"key":"10.1016\/j.phrs.2020.105048_bib0200","series-title":"Grand View Research, Artemisinin Combination Therapy Market Worth $697.9 Million by 2025: Grand View Research, Inc.","year":"2019"},{"key":"10.1016\/j.phrs.2020.105048_bib0205","series-title":"21st Century Business Herald, Breaking Through the \u201cPublic Sector\u201d: Opportunities for Chinese Pharmaceutical Companies Regarding Artemisinin","year":"2015"},{"key":"10.1016\/j.phrs.2020.105048_bib0210","series-title":"Chinese Nobel Laureate \u2018Cautiously Optimistic\u2019 About Progress Towards Lupus Treatment","author":"Fifi","year":"2019"},{"key":"10.1016\/j.phrs.2020.105048_bib0215","series-title":"KPC Pharma Soars After Saying Chinese Nobel Laureate\u2019s New Drug Is in Clinical Trials","author":"Liao","year":"2019"},{"key":"10.1016\/j.phrs.2020.105048_bib0220","series-title":"Prequalified Lists of Medicines\/Finished Pharmaceutical Products","author":"WHO","year":"2020"},{"issue":"5","key":"10.1016\/j.phrs.2020.105048_bib0225","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.respol.2013.08.013","article-title":"Co-ownership of intellectual property: exploring the value-appropriation and value-creation implications of co-patenting with different partners","volume":"43","author":"Belderbos","year":"2014","journal-title":"Res. Policy"},{"issue":"6","key":"10.1016\/j.phrs.2020.105048_bib0230","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1540-5885.2010.00757.x","article-title":"Technological activities and their impact on the financial performance of the firm: exploitation and exploration within and between firms","volume":"27","author":"Belderbos","year":"2010","journal-title":"J. Prod. Innov. Manage."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2020.105048_bib0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/mde.1078","article-title":"Joint patenting amongst companies\u2012exploring the effects of inter\u2010firm R&D partnering and experience","volume":"24","author":"Hagedoorn","year":"2003","journal-title":"Manage. Decis. Econ."},{"key":"10.1016\/j.phrs.2020.105048_bib0240","first-page":"373","article-title":"Pharmaceutical public-private partnerships: moving from the bench to the bedside","volume":"4","author":"Bagley","year":"2014","journal-title":"Harv. Bus. Law Rev."},{"key":"10.1016\/j.phrs.2020.105048_bib0245","series-title":"\u201c4+7\u201d Drug Procurement Reform in China","author":"Xiao","year":"2019"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820313566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820313566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:23:52Z","timestamp":1760912632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820313566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":49,"alternative-id":["S1043661820313566"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105048","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global research on artemisinin and its derivatives: Perspectives from patents","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105048"}}